» Articles » PMID: 38844804

Anti-Inflammatory Activities of (+)-Afzelechin Against Lipopolysaccharide-Induced Inflammation

Overview
Specialty Pharmacology
Date 2024 Jun 6
PMID 38844804
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we investigated the potential protective effects of (+)-afzelechin (AZC), a natural compound that is derived from Bergenia ligulata, on lipopolysaccharide (LPS)-induced inflammatory responses. AZC is known to have antioxidant, anticancer, antimicrobial, and cardiovascular protective properties. However, knowledge regarding the therapeutic potential of AZC against LPS-induced inflammatory responses is limited. Thus, we investigated the protective attributes of AZC against inflammatory damage caused by LPS exposure. We examined the effects of AZC on heme oxygenase (HO)-1, cyclooxygenase (COX)-2, and inducible nitric oxide synthase (iNOS) in LPS-activated human umbilical vein endothelial cells (HUVECs). In addition, the effects of AZC on the expression of iNOS, tumor necrosis factor (TNF)-α, and interleukin (IL)-1β were analyzed in the lung tissues of LPS-injected mice. Data revealed that AZC promoted the production of HO-1, inhibited the interaction between luciferase and nuclear factor (NF)-κB, and reduced the levels of COX-2/PGE2 and iNOS/NO, thereby leading to a decrease in the signal transducer and activator of transcription (STAT)-1 phosphorylation. Moreover, AZC facilitated the nuclear translocation of Nrf2, increased the binding activity between Nrf2 and the antioxidant response elements (AREs), and lowered the expression of IL-1β in the LPS-treated HUVECs. In the animal model, AZC significantly reduced the expression of iNOS in the lung tissue structure and the TNF-α level in the bronchoalveolar lavage fluid. These findings demonstrate that AZC possesses anti-inflammatory properties that regulate iNOS through the inhibition of both NF-κB expression and p-STAT-1. Consequently, AZC has potential as a future candidate for the development of new clinical substances for the treatment of pathological inflammation.

Citing Articles

Effect of (R)-(-)-Linalool on endothelial damage: Sex differences.

Doro L, Peana A, Migheli R, Capobianco G, Criscione M, Montella A Biochem Biophys Rep. 2024; 40:101846.

PMID: 39483177 PMC: 11525626. DOI: 10.1016/j.bbrep.2024.101846.

References
1.
Liu H, Yu X, Yu S, Kou J . Molecular mechanisms in lipopolysaccharide-induced pulmonary endothelial barrier dysfunction. Int Immunopharmacol. 2015; 29(2):937-946. DOI: 10.1016/j.intimp.2015.10.010. View

2.
McInnes I, Schett G . The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011; 365(23):2205-19. DOI: 10.1056/NEJMra1004965. View

3.
Tsoyi K, Nizamutdinova I, Jang H, Mun L, Kim H, Seo H . Carbon monoxide from CORM-2 reduces HMGB1 release through regulation of IFN-β/JAK2/STAT-1/INOS/NO signaling but not COX-2 in TLR-activated macrophages. Shock. 2010; 34(6):608-14. DOI: 10.1097/SHK.0b013e3181e46f15. View

4.
Wullaert A, Bonnet M, Pasparakis M . NF-κB in the regulation of epithelial homeostasis and inflammation. Cell Res. 2010; 21(1):146-58. PMC: 3193399. DOI: 10.1038/cr.2010.175. View

5.
Garimella T, Jolly C, Narayanan S . In vitro studies on antilithiatic activity of seeds of Dolichos biflorus Linn. and rhizomes of Bergenia ligulata Wall. Phytother Res. 2001; 15(4):351-5. DOI: 10.1002/ptr.833. View